Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 136–150 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4914 IL1RAPL1 Gene Intellectual Disability, X‑linked Type 21 (MRX21) Genetic Test This test detects genetic variants in the IL1RAPL1 gene associated with X-linked intellectual disability type 21 (MRX21).	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic and likely pathogenic variants in the IL1RAPL1 gene", "Single-nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform the lab of any medications being taken"] Indications ["Diagnosis of X-linked intellectual disability type 21 (MRX21)", "Individuals with clinical features suggestive of MRX21", "Family history of MRX21", "Genetic counselling for families with MRX21"] Measurement technique Confirm with laboratory Codes LOINC: 94222-8 ICD-10: F79, Q99.8, Z13.79 Clinical summary This test detects genetic variants in the IL1RAPL1 gene associated with X-linked intellectual disability type 21 (MRX21).
TEST-2969 IMPAD1 Gene NGS Test for Chondrodysplasia with Joint Dislocations (GPAPP Type) This test identifies pathogenic variants in the IMPAD1 gene associated with chondrodysplasia with joint dislocations (GPAPP type).	Peripheral Whole Blood or Extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the IMPAD1 gene", "Full gene coverage", "Copy Number Variations (CNV)"] Parameters [] Preparation [] Indications ["Suspected chondrodysplasia with joint dislocations (GPAPP type)", "Family history of skeletal dysplasia", "Need for accurate prognosis and genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q78.8 Clinical summary This test identifies pathogenic variants in the IMPAD1 gene associated with chondrodysplasia with joint dislocations (GPAPP type).
TEST-4647 INPP5E Gene Joubert Syndrome Type 1 Genetic Test This test identifies pathogenic variants in the INPP5E gene associated with Joubert syndrome type 1.	Whole blood, extracted DNA, or one-drop blood on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in INPP5E gene", "Single-nucleotide changes", "Small insertions/deletions"] Parameters [] Preparation ["Attend mandatory pre-test genetic counselling session", "No fasting or medication adjustment required unless advised by doctor"] Indications ["Confirmation of clinical diagnosis", "Carrier testing", "Guiding personalized neurological management"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q04.3 Clinical summary This test identifies pathogenic variants in the INPP5E gene associated with Joubert syndrome type 1.
TEST-2468 IRF6 Gene Orofacial Cleft Type 6 Genetic Test This diagnostic test evaluates the IRF6 gene for pathogenic variants associated with orofacial cleft type 6 (Van der Woude syndrome).	Peripheral blood (whole blood), Extracted DNA, or One-drop Blood on FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IRF6 gene coding region", "Selected intronic boundaries", "Deletions and duplications within the IRF6 gene"] Parameters [] Preparation ["No specific fasting required.", "No medication or diet restrictions."] Indications ["Diagnosis of orofacial cleft type 6 (Van der Woude syndrome)", "Familial risk assessment for clefting", "Preconception genetic screening for couples with a history of clefting", "Informing multidisciplinary management of newborns with cleft palate or lip"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q38.0, Q37.9 Clinical summary This diagnostic test evaluates the IRF6 gene for pathogenic variants associated with orofacial cleft type 6 (Van der Woude syndrome).
TEST-4311 KCNB1 Gene Early Infantile Epileptic Encephalopathy Type 26 Genetic Test This genetic test identifies pathogenic variants in the KCNB1 gene associated with Early Infantile Epileptic Encephalopathy Type 26.	Whole Blood (EDTA) – Peripheral Blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KCNB1 gene"] Parameters [] Preparation ["Mandatory genetic counselling session", "No fasting required"] Indications ["Infants with refractory seizures and neurodevelopmental delay", "Suspected Early Infantile Epileptic Encephalopathy Type 26"] Measurement technique Confirm with laboratory Codes LOINC: 82322-2 ICD-10: G40.4 Clinical summary This genetic test identifies pathogenic variants in the KCNB1 gene associated with Early Infantile Epileptic Encephalopathy Type 26.
TEST-4208 KCTD17 Gene DYT26 Myoclonic Dystonia Genetic Test This genetic test identifies mutations in the KCTD17 gene associated with autosomal dominant myoclonic dystonia (DYT26). It sequences the entire coding region to detect pathogenic...	Peripheral Whole Blood (3–5 mL in EDTA tube) or DNA FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KCTD17 gene sequence", "Pathogenic variants in coding exons and splice junctions"] Parameters [] Preparation [] Indications ["Unexplained myoclonus and dystonia", "Family history of myoclonic dystonia", "Prenatal diagnosis with known familial mutation"] Measurement technique Confirm with laboratory Codes LOINC: 51958-3 ICD-10: G24.1 Clinical summary This genetic test identifies mutations in the KCTD17 gene associated with autosomal dominant myoclonic dystonia (DYT26). It sequences the entire coding region to detect pathogenic variants.
TEST-4952 KIF1A‑Related Intellectual Disability (MRD9) Genetic Test This test identifies pathogenic variants in the KIF1A gene associated with intellectual disability and related neurological symptoms.	Peripheral Whole Blood (FTA Card or Venous Blood Draw)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs) in KIF1A gene", "Small insertions/deletions (indels) in KIF1A gene", "Copy number variations (CNVs) in KIF1A gene"] Parameters [] Preparation ["No specific fasting required", "Maintain current medications unless advised otherwise"] Indications ["Clinical suspicion of KIF1A-related intellectual disability", "Family history of KIF1A-related disorders", "Confirmation of diagnosis", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 82367-7 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the KIF1A gene associated with intellectual disability and related neurological symptoms.
TEST-2818 KIF1BP Gene GOSHS Genetic Test This test identifies pathogenic variants in the KIF1BP gene, confirming a diagnosis of Goldberg-Shprintzen megacolon syndrome (GOSHS).	Whole Blood (EDTA tube), FTA card dried blood spot, or extracted DNA	3–4 Weeks (from sample receipt at laboratory)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KIF1BP gene", "Homozygous or compound heterozygous mutations"] Parameters [] Preparation ["Consult supervising physician regarding discontinuation of prokinetics, enteral feeds, or parenteral nutrition.", "No fasting required for blood draw."] Indications ["Suspected Goldberg-Shprintzen megacolon syndrome (GOSHS)", "Differential diagnosis for Hirschsprung disease", "Evaluation of severe neonatal or pediatric constipation"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Q87.8, Q43.8, Z15.89 Clinical summary This test identifies pathogenic variants in the KIF1BP gene, confirming a diagnosis of Goldberg-Shprintzen megacolon syndrome (GOSHS).
TEST-2762 KIF1BP Gene Hirschsprung Disease Genetic Test This test analyzes the KIF1BP gene for pathogenic variants associated with Hirschsprung disease.	Whole Blood (EDTA, Lavender-Top Tube), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KIF1BP gene", "Single-nucleotide variants", "Small insertions or deletions", "Copy-number alterations"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Infants, children, or adults with clinical features suggestive of Hirschsprung disease", "Asymptomatic siblings or first-degree relatives of a proband with a known KIF1BP pathogenic variant for carrier testing and recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-6 ICD-10: Q43.1, Z15.89, Z13.71 Clinical summary This test analyzes the KIF1BP gene for pathogenic variants associated with Hirschsprung disease.
TEST-5612 KIF1C Gene Spastic Ataxia Type 2, Autosomal Recessive Genetic Test This test identifies pathogenic variants in the KIF1C gene associated with hereditary spastic ataxia type 2.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in KIF1C gene", "Single nucleotide variants (SNVs)", "Insertions/Deletions (indels)", "Copy number changes"] Parameters [] Preparation ["Informed consent and pre-test genetic counselling with a three-generation pedigree chart are mandatory prior to sample collection."] Indications ["Suspected hereditary spastic ataxia type 2", "Family history of spastic ataxia", "Need for genetic counseling and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the KIF1C gene associated with hereditary spastic ataxia type 2.
TEST-5437 KIF5C Gene Neurodevelopmental Malformation and Microcephaly Genetic Test This test evaluates the KIF5C gene for pathogenic variants associated with neurodevelopmental malformations and microcephaly.	Whole Blood (EDTA) or FTA card (3 mL)	2–3 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KIF5C gene"] Parameters [] Preparation [] Indications ["Patients presenting with congenital microcephaly, global developmental delay, or brain malformations with no clear alternative diagnosis.", "Children under evaluation by a paediatric neurologist.", "Individuals with a family history suggestive of autosomal dominant KIF5C-related disorders.", "Individuals pursuing preconception genetic counselling."] Measurement technique Confirm with laboratory Codes LOINC: 101339-6 ICD-10: Q02, Q04.8 Clinical summary This test evaluates the KIF5C gene for pathogenic variants associated with neurodevelopmental malformations and microcephaly.
TEST-2698 KMT2D Gene (Kabuki Syndrome Type 1) Genetic Test This test evaluates the KMT2D gene for pathogenic variants, including point mutations, deletions, and duplications, associated with Kabuki syndrome type 1.	Whole blood (EDTA) or FTA card dried blood spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KMT2D gene sequence", "KMT2D gene copy number variations (CNV)"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medication unless instructed by a physician."] Indications ["Clinical suspicion of Kabuki syndrome type 1", "Family history of Kabuki syndrome type 1", "Need for accurate recurrence risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 92875-3 ICD-10: Q87.0 Clinical summary This test evaluates the KMT2D gene for pathogenic variants, including point mutations, deletions, and duplications, associated with Kabuki syndrome type 1.
TEST-2557 KNL1 Gene MCPH4 Microcephaly Genetic Test This test evaluates the KNL1 gene for pathogenic variants associated with primary microcephaly type 4 (MCPH4).	Peripheral blood (3–5 mL in EDTA) or buccal swab / FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KNL1 gene", "Coding regions and splice junctions of the KNL1 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Clinical suspicion of microcephaly", "Family history of MCPH4", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 92822-6 ICD-10: Q02, Q03.0 Clinical summary This test evaluates the KNL1 gene for pathogenic variants associated with primary microcephaly type 4 (MCPH4).
TEST-5249 KRT14 Gene Dermatopathia Pigmentosa Reticularis Genetic Test This genetic test evaluates the KRT14 gene for pathogenic variants associated with Dermatopathia pigmentosa reticularis.	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KRT14 gene", "Coding region and splice sites of KRT14"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist about current medications"] Indications ["Suspected Dermatopathia pigmentosa reticularis based on clinical presentation", "Need for genetic confirmation to guide management", "Genetic counseling for recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 89989-4 ICD-10: Q82.8 Clinical summary This genetic test evaluates the KRT14 gene for pathogenic variants associated with Dermatopathia pigmentosa reticularis.
TEST-5125 KRT14 Gene Epidermolysis Bullosa Simplex, Dowling-Meara Type DNA Test This test analyzes the KRT14 gene to detect pathogenic variants associated with Epidermolysis Bullosa Simplex, Dowling-Meara type.	Peripheral Whole Blood (or FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KRT14 gene", "Full coding exon coverage", "Splice-site analysis"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Clinical suspicion of Epidermolysis Bullosa Simplex, Dowling-Meara type", "Positive family history of EB", "Need for definitive genetic diagnosis", "Genetic counseling and reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 21663-4 ICD-10: Q81.0 Clinical summary This test analyzes the KRT14 gene to detect pathogenic variants associated with Epidermolysis Bullosa Simplex, Dowling-Meara type.

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.